|Day Low/High||35.17 / 36.01|
|52 Wk Low/High||31.90 / 59.34|
Wall Street rallies to new records as leftover goodwill from Friday's rally pushes stocks to new heights.
The good vibes that carried Wall Street to new records last week lingered on into Monday's session.
The Dow Jones Industrial Average led Wall Street's gains on Monday on leftover goodwill from last week's Trump-inspired rally.
Here's how to trade seven of the most active names on the market.
Allergan is buying body-sculptor Zeltiq. CEO Brent Saunders deems it to be the Botox of 10 years ago and he expects the deal to be immediately accretive.
Stocks edge higher on Monday as good vibes from Friday's record-breaking rally are sustained through the weekend.
The company had been free falling after CEO Erez Vigodman stepped down last week.
That support could become necessary should the blooming flower of tax reform come with a couple of thorns attached.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the year and the quarter ended December 31, 2016.
Cramer shares his views about Disney, the most de-risked entertainment company ever, and wonders why, if Trump is so bad for stocks, there's no correction yet.
Investors should keep an eye on interest rates and oil, but remember next week is still a week of big earnings reports, says Jim Cramer.
Teva's rich dividend yield may be too good to continue.
The Dow holds onto gains as oil prices fall and energy shares slide.
Yes, he's unpredictable, but is that a reason to sell?
Stocks lose steam Tuesday as oil prices fall and energy shares slide.
Mylan settled a pay-for-delay lawsuit over its narcolepsy drug, but its share prices are falling.
Jim Cramer discusses why investors should be cautious after Teva Pharmaceutical's CEO left the company.
The CEO of Teva Pharmaceuticals has left the company, which has faced a series of challenges.
The Jerusalem-based pharmaceutical company named Dr. Yitzhak Peterburg as interim CEO after Erez Vigodman stepped down following a mutual agreement with the board.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today announced that Dr.
For all the trepidation over a Trump administration, retail investors stayed squarely on the bullish side to start the year.
Civil suit claims units of drugmakers Teva and Allergan had a "pay-for-delay" deal on lidocaine patches.
The company's shares jumped 5% midday Friday on rumors that Astrazeneca could buy Acadia.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) today announced that it has filed an abbreviated new drug application (ANDA) with the U.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will release its fourth quarter 2016 financial results on Monday, February 13, 2017 at 7:00 a.
Mylan's shares rose after Teva's claims of patent infringement were rejected, despite the announcement that the FTC is investigating the drugmaker for antitrust violations.
Two industries should largely be avoided under this administration: pharma and retail.